The US Food and Drug Administration and industry worked hard to clear their desks in the days leading up to Thanksgiving, issuing a bevy of drug development announcements. Here are just a few of the week's most notable events:
Sickle cell patients are likely to be thankful for the FDA's review speed this Thanksgiving, as the agency's 25 November...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?